Skip to main content
Premium Trial:

Request an Annual Quote

Millennium and Pfizer Expand Collaboration On Antifungal Targets

Premium

CAMBRIDGE, Mass.--Based on the success of their current partnership, Pfizer will expand its collaboration with Millennium Pharmaceuticals here for the discovery of unique antifungal drug targets and leads. As part of the expansion Pfizer will add more research personnel. The relationship began in March 1995 as a collaboration with ChemGenics Pharmaceuticals, which merged with Millennium a year ago.

In other news, Millennium recently purchased ABI Prism 377 DNA analysis systems from Perkin-Elmer's Applied Biosystems Division to enhance its genetic analysis services, and will serve as a test site for a new 96-lane upgrade feature that Perkin-Elmer claims will increase the sequencers' throughput by 50 percent. The new equipment will be delivered over the next several months.

Filed under

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.